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Axon outgrowth between the spinal cord and the hindlimb of the chick embryo is constrained by three tissues that  
border axon pathways. Growth cones turn to avoid the posterior sclerotome, perinotochordal mesenchyme, and pelvic 
girdle precursor during normal development and after experimental manipulation. We wanted to know if these func- 
tionally similar barriers to axon advance also share a common molecular composition. Since the posterior sclerotome 
differentially binds peanut agglutinin (PNA) and since PNA binding is also typical of prechondrogenic differentiation, 
we examined the pattern of expression of PNA binding sites and cartilage proteoglycan epitopes in relation to axon 
outgrowth. We found that  all three barrier tissues preferentially express both PNA binding sites and chondroitin-6-sul- 
fate (C-6-S) immunoreactivity at the time when growth cones avoid these tissues. Moreover, both epitopes are expressed 
in the roof plate of the spinal cord and in the early limb bud, two additional putative barriers to axon advance. In 
contrast, neither epitope is detected in peripheral axon pathways. In the somites, this dichotomous pattern of expression 
clearly preceded the invasion of the anterior sclerotome by either motor growth cones or neural crest cells. However, in 
the limb, barrier markers disappeared from presumptive axon pathways in concert with the invasion of axons. Since this 
coordinate pattern suggested that  the absence of barrier markers in these axon pathways requires an interaction with 
growth cones, we analyzed the pattern of barrier marker expression following unilateral neural tube deletions. We found 
that  PNA-negative axon pathways developed normally even in the virtual absence of axon outgrowth. We conclude that  
the absence of staining with carbohydrate-specific barrier markers is an independent characteristic of the cells that  
comprise axon pathways. These results identify two molecular markers that  characterize known functional barriers to 
axon advance and suggest that  barrier tissues may impose patterns on peripheral nerve outgrowth by virtue of their 
distinct molecular composition, v 1991 Academic Press, Inc. 
INTRODUCTION 
The development of specific neuromuscular connec- 
tions in the chick embryo is critically dependent on axon 
guidance. It has become clear that  two distinct and ex- 
perimentally dissociable classes of guidance cues con- 
tribute to the stereotyped pat tern of motor axon out- 
growth. General cues influence all subpopulations of 
motor and sensory axons and define the common path- 
ways of nerve outgrowth. In contrast, specific cues influ- 
ence specific subpopulations of axons and direct the de- 
ployment of these subpopulations at points where two 
or more common pathways diverge (Lance-Jones and 
Landmesser, 1981a,b; for review see Landmesser,  1988; 
Tosney, 1991). Although little is known about the cellu- 
lar and molecular mechanisms that  mediate general 
guidance, common axon pathways could, in theory, be 
defined by positive influences that  promote outgrowth 
in prospective axon pathways or by negative influences 
from surrounding tissues that  constrain outgrowth to 
prospective axon pathways. There is strong experimen- 
tal evidence that  common axon pathways are delin- 
eated, at least in part, by the less permissive nature of 
surrounding tissues. In this report  we have identified 
molecular correlates tha t  characterize tissues known to 
constrain axons during peripheral nerve outgrowth in 
the chick embryo. 
Three tissues tha t  lie adjacent to peripheral nerve 
pathways have been experimentally established to act 
as barriers to axon advance based on growth cone re- 
sponses to surgical manipulations (Tosney and Land- 
messer, 1984; Tosney, 1988a; Tosney and Oakley, 1990). 
A structure may be inferred to act as a barrier  if axons 
turn to avoid it during normal development or if it lies 
adjacent to an axon pathway but is not invaded by 
axons. However, experimental manipulations are neces- 
sary to define whether  axon t ra jectory is dependent on 
the suspected barr ier  or on some property of the adja- 
cent pathway. For example, deletion of a bona fide 
barr ier  should abolish turning behavior and lead to the 
spatial expansion of the axon pathway. Similarly, direct 
confrontation of growth cones with a barr ier  should 
elicit turning behavior. The term barr ier  is thus in- 
tended to decribe a structure tha t  has been experimen- 
tally shown to provide axon guidance cues that  result  in 
growth cone avoidance behavior. The term barr ier  is not 
meant to imply a particular mechanism or tha t  the tis- 
sue is completely impervious to axonal invasion. 
The pelvic girdle precursor was the first barr ier  tissue 
to be identified based on these experimental criteria. 
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Barrier function is suggested by the pattern of nerve 
growth; growth cones gather in a plexus that  extends 
along the entire limb base, turn to avoid the girdle pre- 
cursor, and enter the limb as major nerve trunks only 
through regions where the girdle mesenchyme is absent 
(Tosney and Landmesser 1984, 1985). Barrier function 
was confirmed by deletions; in the absence of the girdle, 
precursor axons proceed directly into the limb (Tosney 
and Landmesser, 1984). Since turning behavior is elimi- 
nated at the base of the limb and axon pathways expand 
spatially in the absence of the girdle precursor, axon 
trajectory in this region is normally dependent on the 
restriction of axons by a barrier rather than solely on 
guidance by some feature of the plexus. 
The sclerotome of the posterior half of each somite 
also acts as a barrier to axon advance. Barrier function 
is suggested by the pattern of axon outgrowth; although 
motor axons exit the spinal cord opposite both anterior 
and posterior somite halves, those that  encounter the 
posterior sclerotome turn to avoid it (Dehnbostel and 
Tosney, 1990). This pattern of initial outgrowth leads to 
preferential colonization of the anterior half of each so- 
mite and the segmental arrangement of the spinal 
nerves (Keynes and Stern, 1984). Barrier function has 
been confirmed by deletions and transplantations. In 
the absence of the sclerotome, axons are not restricted 
to the anterior half segment; they extend from the spi- 
nal cord as a continuous sheet (Tosney, 1987,1988a). Sim- 
ilarly, transplanted compound somites consisting of 
multiple posterior half segments exclude motor axons 
(Stern and Keynes, 1987). 
We have recently shown that  the anterior sclerotome 
can be further subdivided into two different functional 
domains. The dorsal anterior sclerotome acts as a path- 
way, whereas the perinotochordal mesenchyme (the 
ventromedial sclerotome that  surrounds the notochord) 
acts as a barrier to axon advance (Tosney and Oakley, 
1990). Barrier function was suggested by the pattern of 
axon outgrowth around the perinotochordal mesen- 
chyme during normal development (Tosney and Land- 
messer, 1985) and in embryos with hypertrophic noto- 
chords (Tosney, 1988a). We confirmed barrier function 
by rotating the neural tube so as to alter the initial direc- 
tion of motor outgrowth and directly confront motor 
growth cones with the perinotochordal mesenchyme. 
Under these conditions, motor axons turn to avoid the 
perinotochordal mesenchyme and project around rather 
than through this tissue at all stages of outgrowth (Tos- 
ney and Oakley, 1990). 
There is also evidence that  the early limb bud may 
present a barrier to axon invasion. Although axons 
enter the plexus region adjacent to the limb bud by 
stage 21, axons do not enter the limb until stage 24, a 
delay of more than a day (Tosney and Landmesser, 
1985). Axons also delay entering young limb buds that  
have been grafted onto older embryos, which suggests 
that  invasion is dependent on properties of the limb bud 
rather than on growth cone capabilities (Swanson and 
Lewis, 1982). Moreover, the mesenchyme of the early 
limb bud has recently been shown to be an inhospitible 
substrate for motor axon advance in vitro (Landmesser, 
1988). 
The cellular and molecular mechanisms that  mediate 
barrier function are as yet unknown. Attention has re- 
cently focused on characterizing differences between an- 
terior and posterior sclerotome since the former acts as 
an axon pathway and the latter acts as a barrier. How- 
ever, differences in the structural organization of scler- 
otome populations cannot account for these funCtional 
differences; neither physical impediments to axon ad- 
vance in the posterior sclerotome nor aligned elements 
that  could channel axons in the anterior sclerotome 
have been revealed by scanning and transmission elec- 
tron microscopy (Tosney, 1988b; Dehnbostel and Tos- 
ney, 1990). The functional differences between anterior 
and posterior sclerotome populations are therefore 
likely to be related to the differential expression of mole- 
cules that  can be detected by growth cones. A marker 
that  distinguishes between sclerotome populations is 
the peanut agglutinin (PNA) binding site (Gal ~1-3 Gal- 
Nac; Lotan et al., 1975), which is preferentially ex- 
pressed in the posterior sclerotome (Stern et al., 1986) 
and thus distinguishes a known axon barrier from an 
adjacent axon pathway. 
We wanted to know if all three of the aforementioned 
functional barriers to axon advance express the PNA 
binding epitope and if they do so during periods when 
axons avoid these tissues. In addition, since PNA bind- 
ing molecules are also expressed by prechondrogenic 
tissues (Aulthouse and Solursh, 1987), we screened a 
number of probes to cartilage proteoglycans to deter- 
mine whether these molecules are also expressed in 
barrier tissues during axon avoidance. Since barrier tis- 
sues are not histologically distinct from axon pathways 
during early outgrowth, we used tubulin antibodies to 
reveal both the timing and the pattern of axon out- 
growth. We found that  the PNA binding epitope and 
chondroitin-6-sulfate immunoreactivity are expressed 
by all three barrier tissues during stages of initial axon 
outgrowth. Neither epitope was detected in axon path- 
ways. 
Although these epitopes were not detected in axon 
pathways, it was unclear if growth cones actually partic- 
ipated in the differential distribution of these barrier 
markers. For example, the absence of these epitopes in 
axon pathways could be due to: (1) degradation by pro- 
teases released from growth cones (Kryostosek and 
Seeds, 1981; Pittman, 1985), (2) an interaction between 
growth cones and the pathway mesenchyme, or (3) the 
presence of nonstaining axons. We therefore asked if 
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the apparent lack of expression in pathways was depen- 
dent on axon outgrowth. By analyzing the pattern of 
PNA binding in the virtual absence of axon outgrowth, 
we experimentally established that  the PNA binding 
pattern is independent of axon outgrowth. 
MATERIALS AND METHODS 
Immunohistochemistry 
White leghorn chick embryos and quail embryos 
(stage 16-25) were carefully staged using the criteria of 
Hamburger and Hamilton ( 1951}. Embryos were decapi- 
tated, eviscerated, and fixed in 4% paraformaldehyde 
with 0.5% cetylperidinium chloride (CPC) in phos- 
phate-buffered saline (PBS) for 2-4 hr at room tempera- 
ture. Preliminary experiments showed that  inclusion of 
CPC in the fixative markedly enhanced the binding of 
PNA to embryonic tissues, particularly in young era- 
bryos. Fixed embryos were washed in PBS and then in- 
filtrated in 5% sucrose (in PBS) for 1-24 hr and in 15% 
sucrose for 18-24 hr at 4°C. Embryos were oriented and 
embedded in a solution of 7.5% gelatin (Sigma, 300 
bloom) and 15% sucrose (in PBS) after infiltration for 
4-6 hr at 37°C. After 24 hr at 4°C the blocks were rapidly 
frozen in isopentane cooled on dry ice. Serial 10-#m fro- 
zen sections were cut through the hindlimb region using 
a Reichert cryostat. At least five embryos from each 
stage studied were sectioned in the transverse plane and 
additional embryos from early stages (16-20) were sec- 
tioned in the frontal plane. We used serial sectioning in 
combination with immunocytochemistry (see below) to 
determine the timing and pattern of nerve outgrowth in 
relation to barrier tissues. Since prospective axon path- 
ways are not histologically distinct from barrier tissues, 
these pathways were defined by comparing nerve pat- 
terns in closely staged embryos. 
Selected sections were reacted with PNA (Vector) and 
binding was detected using goat anti-PNA (Vector) and 
an FITC-conjugated secondary antibody (Sigma). The 
specificity of PNA binding was confirmed by inhibition 
experiments using either D-(+)-galactose or asialofe- 
tuin (Sigma), which bears the Gal ~ 1-3 GalNac epitope 
(Lotan et al., 1975). Staining was also completely abol- 
ished when either PNA or the antibody to PNA was 
excluded from the protocol. Axons were detected in the 
same sections using a monoclonal antibody (6-11-B1) di- 
rected against acetylated a-tubulin (Piperno et al., 1987) 
followed by a RITC-conjugated secondary antibody 
(Jackson Immunoresearch). 6-11-B1 has been shown to 
label most if not all axons at very early stages of develop- 
ment in the zebrafish (Chitnis and Kuwada, 1990). This 
isoform of tubulin is enriched in axons and labels the 
entire distal process to the base of the growth cone (Lim 
et aL, 1989; Chitnis and Kuwada, personal communica- 
tion). 
The following protocol was used for the simultaneous 
localization of axons and PNA binding. PNA was diluted 
in Hepes-buffered saline (HBS: 10 mM Hepes, 0.15 M 
NaC1, 0.1 mM CaC12) containing 1% bovine serum albu- 
min (BSA). Sections were rehydrated in PBS to remove 
gelatin, blocked for 30 min in HBS with 1% BSA and 1% 
normal rabbit serum, incubated for 30 min in PNA (10 
ttg/ml), and washed. Sections were then incubated for 90 
min in mixed primary antibodies (anti-PNA, 1:100; 6-11- 
B1, 1:10), washed, incubated for 90 min in mixed second- 
ary antibodies (rabbit anti-goat-FITC, rabbit anti- 
mouse-RITC; 1:50), washed, and then mounted in 
PBS:glycerol (1:1). 
The distribution of chondroitin-6-sulfate (C-6-S) epi- 
topes was revealed using a monoclonal antibody (5/6/ 
3B3) generated to chondroitinase ABC-digested chon- 
droitin sulfate of cartilage proteoglycan core protein 
(Couchman et aL 1984: Caterson et aL 1985). To localize 
the C-6-S epitope, sections were postfixed in cold 95% 
ethanol, rehydrated in PBS, and digested with chondoi- 
tinase ABC (0.2 units/ml) in 0.1 M Tris-acetate buffer 
with 1% BSA for 1 hr at 37°C. Sections were then 
washed, blocked for 30 min (as above), incubated for 60 
min in 5/6/3B3 (1:50 without Triton), washed, and 
mounted as above. The distribution of axons in relation 
to C-6-S immunoreactivity was defined by staining 
neighboring sections with monoclonal antibody 6-11-B1 
as above. Except where noted, all antibodies were di- 
luted in blocking solution containing 0.5% Triton X-100 
(Sigma), all incubations were at room temperature, and 
all washes were in three changes of PBS. 
We tested several other probes to cartilage-related 
molecules including monoclonal antibodies directed 
against keratan sulfate oligosaccharides (1/20/5D4; 
4/8/1B4 and 4D1) and chondroitinase-digested chon- 
droitin-4-sulfate/dermatan sulfate (Caterson et al., 
1983; Couchman et al., 1984; Caterson et al., 1985). Mono- 
clonal antibodies to chondroitin sulfate epitopes and 
chrondroitinase ABC were obtained from ICN Bio- 
medical. 
Experimental  Embryos 
Neural tubes were unilaterally deleted as previously 
described (Tosney et al., 1988) at stages prior to motor 
axon outgrowth (stages 16-18) in the lumbosacral re- 
gion. Briefly, chick embryos were lightly stained with 
0.25% neutral red in distilled water and the neural tube 
was opened dorsally with a fine tungsten needle. The 
left half of the neural tube was removed over three to 
eight presumptive hindlimb segments by aspiration 
through a small micropipette (tip size 20-40 ttm). 
Operated embryos were moistened with sterile saline 
containing 100 uni ts /ml of penicillin-streptomycin 
(GIBCO) and incubated for an additional 12-48 hr. Em- 
190 DEVELOPMENTAL BIOLOGY VOLUME 147, 1991 
bryos that  appeared normal aside from the neural tube 
deletion and the accompanying spina bifida were fixed 
and processed for double labeling with PNA and 6-11-B1 
as described above. We examined 13 embryos with suc- 
cessful neural tube deletions at stages after axons had 
entered the limb on the unoperated side (stages 25-26). 
Six of these had major deletions (>90%) of both sensory 
and motor populations. These embryos were used to 
measure the anterior/posterior extent of the PNA-neg- 
ative dorsal crural nerve pathway. Twelve additional ex- 
perimental embryos were examined at various earlier 
stages of outgrowth (stages 19-23). 
RESULTS 
Expression of  Barrier Markers and the Development of  
Peripheral Nerve Pathways 
If a molecule is to be considered as a marker for 
barrier function, it must, at minimum, be expressed at 
the right time and place. We therefore examined the 
spatial and temporal patterns of expression of PNA 
binding and C-6-S epitopes prior to and during the out- 
growth of axons from the spinal cord to the hindlimb. 
We have focused on these markers because, of the 
various probes screened in this study (see Materials and 
Methods), only these two were selectively expressed in 
all barrier tissues during early motor outgrowth. 
We found preferential PNA binding and C-6-S immu- 
noreactivity in the posterior half of each epithelial so- 
mite before the outgrowth of motor axons and before 
the onset of neural crest migration. PNA binding sites 
and C-6-S immunoreactivity were detected around pos- 
terior cells within the cores of recently segmented epi- 
thelial somites (Figs. 1A and 1B). These epitopes were 
not detected in the somitic epithelium itself or in the 
core cells in the anterior halves of somites. This differ- 
ential binding pattern was detected in somites just  two 
segments anterior to the segmental plate. Since neural 
crest cells invade the anterior half of each somite only 
after dispersal of the epithelial somite (approximately 5 
somites anterior to the segmental plate; Loring and Er- 
ickson, 1987), and since motor axons enter the somite 
somewhat later (approximately 10-15 somites anterior 
to the segmental plate; Tosney, 1988), the asymmetric 
expression of PNA binding sites and C-6-S develops 
early enough to mediate the exclusion of both crest cells 
and motor axons from the posterior half somite. These 
findings are contrary to those of Stern and colleagues, 
who were unable to detect an asymmetry of PNA bind- 
ing during stages relevant to neural crest migration 
(Davies et al., 1990), but are in agreement with a recent 
report by Newgreen et al. (1990) on the pattern of C-6-S 
expression in early somites. Two factors are likely to 
have contributed to the differences between our results 
and those of Davies et al. (1990); the preservation and 
detection of PNA binding sites in our studies was mark- 
edly enhanced by the inclusion of CPC in the fixative 
and by the use of antibodies to PNA. 
Following the dispersal of epithelial somites into a 
mesenchymal sclerotome and epithelial dermamyo- 
tome, both carbohydrate epitopes are preferentially ex- 
pressed in the sclerotomal portion of each posterior half 
somite. PNA binding sites and C-6-S immunoreactivity 
were detected in the posterior sclerotome during the ear- 
liest stages of motor axon outgrowth. In contrast, nei- 
ther epitope was detected in the adjacent anterior scler- 
otome (Figs. 1C-1E). The expression of PNA binding 
sites and C-6-S epitopes in the posterior sclerotome thus 
distinguishes this known functional barrier to axon ad- 
vance from an adjacent axon pathway, the anterior 
sclerotome. 
Although both carbohydrate epitopes are preferen- 
tially expressed in the posterior sclerotome in the chick, 
the posterior sclerotome of the quail embryo has re- 
cently been shown to lack PNA binding sites and the 
relevance of these sites to the patterning of motor axons 
and neural crest cells has been questioned (Asamato et 
al., 1990). We confirm the absence of PNA binding in the 
posterior sclerotome of the quail embryo (not shown). 
However, we did find that  C-6-S immunoreactivity is 
preferentially expressed in the posterior sclerotome of 
quail embryos during early stages (Fig. 1F). Thus, the 
quail embryo does express an asymmetric molecular 
distribution in the posterior sclerotome that is corre- 
lated with the exclusion of motor axons and neural crest 
cells. 
We also found that  the perinotochordal mesenchyme 
in the anterior as well as the posterior half of each seg- 
ment expresses both PNA binding sites and C-6-S immu- 
noreactivity. Both epitopes were detected in the perino- 
tochordal mesenchyme during the early stages of motor 
outgrowth (stage 19 at the hindlimb level). PNA binding 
in the anterior half of each segment was specifically 
limited to the mesenchyme and extracellular matrix 
surrounding the notocord and did not include the pro- 
spective spinal nerve pathway or the more dorsal ante- 
rior sclerotome. Motor axons ramify extensively 
throughout the dorsal anterior sclerotome, which does 
not bind the lectin (Figs. 2A-2B). More laterally, the 
dorsal anterior sclerotome is a narrow zone between the 
developing myotome and the perinotochordal mesen- 
chyme (Figs. 2A-2B and 3C-3D). Axons are confined to 
this narrow zone, which is devoid of PNA binding. No 
axons were found to ramify within the perinotochordal 
mesenchyme. In contrast, PNA binding in the posterior 
half of each segment extended further dorsal and lateral 
to include the entire sclerotome (Fig. 2C). C-6-S immuno- 
reactivity had a similar distribution in both chick and 
quail embryos (Figs. 2E-2F). However, expression was 
strongest in the more medial perinotochordal region 
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Fzo. 1. PNA binding and C-6-S expression are shown in frontal sections of somites near the level of the ventral roots before (A, B) and during 
(C-F) motor axon outgrowth. Anterior is to the right. (A) PNA differentially binds within the posterior halves (arrows) of recently segmented 
somites prior to neural crest or axon invasion. The youngest somite, at left, is located two somites anterior to the segmental plate; the earliest 
detectable motor outgrowth in this stage 17 embryo was nine more segments toward the anterior. (B) C-6-S immunoreactivity is also differen- 
tially expressed within the posterior halves (arrows) of epithelial somites. The somite on the left is located three somites anterior to the 
segmental plate in this stage 16 embryo. Both epitopes are limited to mesenchymal populations within the posterior core of somites; neither 
epitope is detected within the epithelial portion of somites. (C, D) The same section from the thoracic level of a stage 17 embryo, a level where 
axons have begun to traverse the sclerotome. (C) PNA binds the posterior (ps) but not the anterior (as) sclerotome during early motor 
outgrowth. Also note PNA binding within the spinal cord at the level of the ventral roots (between arrowheads). (D) Axons (arrows) are 
revealed here and in subsequent figures using antibody 6-11-B1 which recognizes acetylated a-tubulin; this antibody also displays punctate 
label within the dermamyotome (dm). Axons traverse only the PNA-negative, anterior sclerotome; axons that initially exit the spinal cord 
opposite the posterior sclerotome (e.g., arrowhead) turn to avoid the PNA binding regions. Unlike motor axons, commissural axons (small 
arrows in D) traverse a path within the lateral margin in the spinal cord (s) which expresses PNA binding sites (between arrowheads in C). (E, 
F) C-6-S immunoreactivity is also detected in the posterior (ps) but not anterior (as) sclerotome during early motor outgrowth in chick (E) and 
quail (F) embryos (thoracic level, stage 17). Both PNA binding sites and C-6-S are also expressed around the notochord (n in B, E, F) and in the 
predermal space (d in A, B, C, E, F) between the ectoderm and the dermamyotome. These and all subsequent figures are fluorescence micro- 
graphs of frozen sections, s, spinal cord. Calibration bars = 50 tLm. 
and  d id  no t  ex t end  as f a r  l a t e r a l  as P N A  b i n d i n g .  More-  
over, C-6-S is expressed  w i t h i n  the  no tochord ,  wh ich  
was  c o n s i s t e n t l y  P N A - n e g a t i v e  a t  a l l  s t ages  s t ud i e d  
(also c o m p a r e  Figs.  5A a n d  5E). 
Thus ,  the  s p i n a l  ne rve  p a t h w a y  t h r o u g h  the  sclero-  
tome  can  be defined by  the  absence  of s t a i n i n g  w i t h  ei- 
t h e r  P N A  or C-6-S-specific a n t i bod i e s .  The  p a t t e r n  of 
exp res s ion  of these  ep i topes  in  the  s c l e ro tome  is t h e r e -  
fore  s t r o n g l y  c o r r e l a t e d  w i t h  b a r r i e r  f u n c t i o n ;  bo th  epi-  
topes  a re  p r e f e r e n t i a l l y  expressed  in  b a r r i e r  r eg ions  of 
the  s c l e ro tome  (pos te r io r  s c l e ro tome  a n d  p e r i n o t o c h o r -  
dal  m e s e n c h y m e )  b u t  a re  no t  de tec ted  in  the  axon  p a t h -  
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FIG. 2. PNA binding (A, C) and C-6-S immunoreaetivity (E,F) during early motor outgrowth are shown in traverse sections through somites 
at  hindlimb levels of stage 19 embryos. (A,B) The same section through the anter ior  portion of a somite. (A) PNA binds to the perinotochordal 
mesenchyme (pnm) but  not to the dorsal anterior  sclerotome (das) which acts as a pathway for axons. PNA also binds the roof plate (rp) and 
lateral margins (1) of the spinal cord as well as the predermal space (d). (B) Motor axons (arrows) extending toward the myotome (m) ramify 
widely in the PNA-negative dorsal anter ior  sclerotome. A distally directed motor axon (curved arrow) projects along the narrow, PNA-nega - 
tive, distal portion of the dorsal anter ior  sclerotome (curved arrow in A). (C, D) The same section through the posterior portion of a somite. (C) 
PNA binding in the posterior sclerotome (ps) is not confined to the perinotochordal region, it extends more dorsally and laterally to include the 
entire sclerotome (compare to A). (D) Motor axons have turned along the anter ior /poster ior  axis to avoid the posterior sclerotome after  leaving 
the spinal cord and are cut in cross section (arrow). (E, F) Comparison of C-6-S immunoreactivity in the anterior  halves of somites from chick 
(E) and quail (F) embryos. In both species, C-6-S immunoreactivity is not detected in dorsal anter ior  sclerotome (das) and is differentially 
expressed in the perinotochordal mesenchyme (pnm) and in the predermal space (d). However, the C-6-S immunoreactivity within these tissues 
is less spatially extensive than  is the PNA binding (compare to A). n, notochord; s, spinal cord. Calibration bars = 50 #m. 
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FIG. 3. The plexus region of the hindlimb, an unsegmented axonal 
pathway, does not bind PNA. (A) This frontal section is of a stage 18 
embryo, before the plexus is invaded by the first motor axons. PNA 
binds the posterior sclerotome (ps) of each somite and uniformly 
binds the limb bud mesenchyme (lm) but does not bind the anterior 
sclerotome (as) or the plexus region (px) that extends along the entire 
base of the limb (between arrows). The section is oblique and shows 
the notochord (n) and perinotochordal mesenchyme (pnm) toward the 
anterior (at right). (B, C) The same transverse section from the mid- 
hindlimb level at stage 20, when axons are first reaching the plexus 
region. (B) PNA binds the perinotochordal mesenchyme (pnm) and 
the limb bud mesenchyme (lm) but not the dorsal anterior sclerotome 
(das) or the plexus mesenchyme (px). (C) Axons (curved arrow) in the 
spinal nerve are approaching but have not yet colonized the plexus 
region. Also note axons (arrow) in the dorsal anterior sclerotome and 
way. Moreover,  these  c a r b o h y d r a t e  epi topes are  ex- 
pressed  before  and dur ing  the period when  these  b a r r i e r  
regions are  avoided by mo to r  g rowth  cones. 
Af t e r  t r a v e r s i n g  the  sclerotome,  the  spinal  nerves  
converge at the  base of the  l imb and expand along the  
a n t e r i o r - p o s t e r i o r  axis to fo rm an unsegmen ted  plexus 
t h a t  is charac te r i zed  by the absence of s t a in ing  with  
e i ther  PNA-  or C-6-S-specific ant ibodies.  We found t h a t  
the plexus region does not  b ind PNA even a t  s tages  pr ior  
to the  invasion of this  region by the  ear l ies t  axons. Fig- 
ure 3A i l lus t ra tes  a s tage  18 embryo  in oblique f ronta l  
section dur ing  ear ly  moto r  ou tgrowth  and pr ior  to ax-  
onal  invasion of the plexus region. Al though PNA 
s t rongly  binds to both the pos ter ior  sc le ro tome and the  
undi f fe ren t ia ted  l imb bud mesenchyme  (see below), the 
mesenchyme  of the plexus region did not  bind the lectin. 
T ransve r se  sections (Figs. 3B-3C) also i l lus t ra te  PNA 
binding wi th in  the per ino tochorda l  mesenchyme  but  
not in the plexus m e s e n c h y m e  as the  first  axons ap- 
proach  the  plexus region. The unsegmen ted  c h a r a c t e r  of 
the plexus m e s e n c h y m e  is the re fo re  cor re la ted  wi th  the  
absence of PNA binding and the  spat ia l  expansion of 
axonal  pa thways .  
The m e s e n c h y m o  t h a t  cons t i tu tes  the p r e sumpt ive  
pelvic girdle also expresses  both PNA binding s i tes  and 
C-6-S immunoreac t iv i ty ,  whe reas  these  epi topes are  not  
detected in the p a t h w a y s  t h a t  t r a n s m i t  axons f rom the 
plexus to the l imb th rough  the girdle  region. This  corre-  
la t ion is bes t  apprec ia ted  by compar ing  the  p a t t e r n s  of 
p re fe ren t i a l  PNA binding in cross sect ions f r o m  differ- 
ent  axial  levels, since axons extend into the l imb as two 
m a j o r  nerve  t runks  in the  c rura l  (anter ior )  and sciatic 
(poster ior)  regions but  do not  t r ave r se  the cen t ra l  girdle  
region a t  the  mid th igh  level unless the girdle  mesen-  
chyme is surgical ly  deleted (Tosney and Landmesse r ,  
1984, 1985). A t  the  mid th igh  level, we detected p re fe ren-  
t ial  P N A  binding and C-6-S i m m u n o r e a c t i v i t y  in the  
prospect ive  girdle m e s e n c h y m e  la te ra l  to the plexus as 
axons first  begin to popula te  the  plexus region (Figs. 
4A-4B). A t  this  axial  level, the  prospect ive  girdle  region 
dis ta l  to the nerve f ron t  p resen t s  a cont inuous  b a r r i e r  to 
axon advance  t h a t  is charac te r i zed  by  the  express ion of 
both  c a r b o h y d r a t e  epitopes.  Axons  do not  t r ave r s e  the  
girdle  region a t  th is  axial  level; t hey  tu rn  in the  an te -  
r i o r / p o s t e r i o r  axis and ex tend  a long the  PNA-nega t i ve  
plexus region (Figs. 4C-4D). 
In cont ras t ,  in the  c rura l  and sciat ic regions,  axons 
t r ave r s e  discont inui t ies  in the  girdle  m e s e n c h y m e  t h a t  
in i t ia l ly  express  lower levels of P N A  binding and  C-6-S 
immunoreac t iv i ty ;  the  in tens i ty  of  s ta in ing  in these  
axon p a t h w a y s  then  declines as axons invade the  l imb. 
The c rura l  region is i l lus t ra ted  in Fig. 5. As axons en te r  
the absence of axons in the perinotochordal mesenchyme, n, noto- 
chord; s, spinal cord. Calibration bars = 100 ~m. 
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FIG. 4. Transverse sections at  the midhindlimb level document pat terns  of PNA binding to the pelvic girdle precursor which acts as a 
continuous barr ier  at  this axial level. (A, B) The same section through a stage 22 embryo, after  axons have entered the plexus. (A) PNA binding 
in the proximal limb is now confined to the pelvic girdle precursor (g) and extends along the full dorsal-ventral  axis at  the limb base. PNA does 
not bind the plexus region (px) but labels the perinotochordal mesenchyme (pnm) and axial dermis (d) at  this stage. (B) Axons in the spinal 
nerves (small arrows) have colonized the plexus region but turn upon contacting the PNA-positive girdle precursor and are cut in cross section 
(arrows). (C,D) The same section from a stage 25 embryo; by this stage, axons have penetrated the limb at  more anterior  (crural) and more 
posterior (sciatic) levels (see Figs. 5, 6). (C) PNA binding fully delineates the midlimb region of the pelvic girdle precursor (g) and extends along 
its entire dorsal-ventral  axis just  distal to the plexus region. The plexus region (px) and the ventral  crural nerve t runk nerve pathway (curved 
black arrow) tha t  lies ventromedial  to the girdle do not bind the lectin. (D) Axons traverse only PNA-negative regions; they extend to the base of 
the limb, turn along the anter ior /poster ior  axis within the plexus (arrows) and within the ventral  nerve t runk pathway (curved arrows), n, 
notochord; s, spinal cord. Calibration bars = 100 t~m. 
this plexus its distal border is delimited by a relatively 
homogeneous mesenchyme that  strongly binds PNA. Be- 
tween stage 21 and 23, a region of low PNA binding 
emerges between the PNA-positive dorsal and ventral 
portions of the presumptive girdle (Fig. 5A). During this 
period, axons begin to extend into the limb and their 
ultimate course between the girdle elements is marked 
by this region of low PNA binding (compare Figs. 5A-5B 
with Figs. 5C-5D). The expression of C-6-S immunoreac- 
tivity in the presumptive girdle in this region is essen- 
tially similar in both timing and pattern in the chick 
(Fig. 5E) and quail (not shown). Moreover, PNA 
strongly labels the presumptive girdle but not the axon 
pathways in the quail (Fig. 5F). The sciatic region, 
where axons enter the limb in restricted regions by 
growing between the presumptive girdle elements and 
the presumptive femur, displays a similar pattern (Fig. 
6). As axons begin to fill this plexus, we detected PNA 
binding to the girdle elements and the presumptive fe- 
mur. By stage 23, axons begin to form dorsal and ventral 
sciatic nerve trunks by branching around the proximal 
end of the PNA-positive femur (Figs. 6A-6B). The pro- 
spective course of these nerves into the limb is delin- 
eated by two regions of lower PNA binding between gir- 
dle elements and the femur; these two regions are later 
invaded by axons (compare Figs. 6A-6B with Figs. 6C- 
6D). The pattern of PNA binding in the sciatic region 
was identical in chick and quail (not shown). The timing 
and pattern of C-6-S expression in both chick (Fig. 6E) 
and quail (not shown) were similar to those of PNA bind- 
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FIG. 5. At  the crural axial level i l lustrated here in t ransverse sections, axons enter  the limb by growing through gaps between developing 
girdle elements; these gaps express lower levels of PNA binding.sites (A, C, F) and C-6-S immunoreactivity (E). (A, B) The same section from a 
stage 23 chick. (A) PNA binds the dorsal (dg) and ventral  (vg) girdle elements; a PNA-negative gap (arrow) in the prospective dorsal crural 
nerve pathway is less distinct than at later stages but is already detectable between the girdle elements. PNA binding is also absent  from the 
plexus region (px). PNA binding sites continue to be expressed in the roof plate (rp) and lateral margins (1) of the spinal cord (S) and delimit the 
medial boundaries (arrowheads) of the motor columns. (B) Axons tha t  have begun to extend from the plexus region to the limb are confined to 
the PNA-negative dorsal nerve pathway (arrow). (C, D) The same section from a stage 25 chick. (C) PNA binds the dorsal (dg) and ventral  (vg) 
girdle elements which surround the PNA-negative dorsal nerve t runk pathway (arrows). PNA binding is also absent from the ventral  nerve 
t runk pathway (curved arrows) which is visible in this  section ventromedial to the girdle. (D) Axons of the dorsal (arrows) and ventral  (curved 
arrows) crural nerve t runks extend into the limb through the PNA-negative regions. (E) C-6-S immunoreactivity is also localized to the dorsal 
(dg) and ventral  (vg) girdle elements tha t  surround regions of low expression, the dorsal (arrow) and ventral  (curved arrow) crural nerve 
pathways. Also note label in the lateral margins  of the spinal cord (1), in the roof plate (rp), and bordering the medial portion of the motor 
columns (arrowheads; compare to PNA label in Fig. 5A). Stage 23 chick. (F) In the quail embryo, PNA also binds the crural girdle elements (dg, 
vg) in a similar pattern.  In particular, regions of lower expression correspond to the incipient dorsal (arrows) and ventral  (curved arrows) nerve 
t runk pathways (stage 23 quail), n, notochord; s, spinal cord. Calibration bars = 100 #m. 
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FIG. 6. In the sciatic region i l lustrated here in transverse sections, axons enter  the limb by growing between the developing girdle elements 
and the presumptive femur; these gaps express lower levels of PNA binding sites (A, C) and C-6-S immunoreactivity (E). (A, B) Comparison of 
pat terns  of PNA binding and axon advance in the same section of a stage 23 chick. (A) PNA binds the dorsal (dg) and ventral  (vg) girdle 
elements and the presumptive femur (f). PNA-negative gaps (open arrows) between the girdle elements and the femur mark the prospective 
paths of the dorsal and ventral  sciatic nerve trunks. (B) The nerve t runks (arrows) have begun to branch around the proximal end of the 
presumptive femur and enter  the PNA-negative gaps. (C, D) Comparison of pat terns  of PNA binding and axon advance in the same section of a 
stage 25 chick. (C) PNA-negative gaps (open arrows) are prominent  between the girdle elements (dg, vg) and the presumptive femur (f). (D) 
Axons (arrows) in the sciatic nerve t runks branch around the presumptive femur and are t ransmit ted  to the limb through the PNA-negative 
gaps. Note tha t  axons grow around ra ther  than  through the PNA-positive presumptive femur. (E) C-6-S immunoreactivity is expressed in the 
girdle elements (dg, vg) and presumptive femur (f) but is not detected in the sciatic nerve pathways (open arrows) as shown in this section of a 
stage 25+ chick. While the pat tern  is very similar to tha t  of PNA binding (compare to C), C-6-S is consistently expressed to a more limited 
spatial  extent in the perinotochordal mesenchyme (pnm) and is also expressed in the notochord (n). The C-6-S antibody also consistently labels 
the femur more intensely than  the girdle precursor, ps, posterior sclerotome. (F) C-4-S/DS immunoreactivity in the sciatic region. Unlike C-6-S, 
C-4-6/DS is not detected in the girdle; moreover, it is expressed in the sciatic nerve pathway (open arrows, compare to D and E) as well as in the 
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ing. Thus, the prospective nerve pathways through the 
girdle region are marked by regions that  do not stain 
with PNA- or C-6-S-specific antibodies. 
PNA Binding in the Absence of  Axon Outgrowth 
Since the decline in PNA binding and C-6-S immuno- 
reactivity is essentially coordinate with the accumula- 
tion of growth cones in the plexus region and their ex- 
tension toward the limb, the pattern of staining with 
these probes could be dependent on the presence of 
growth cones. For example, extracellular materials 
could be differentially digested in these regions by pro- 
teases, which are known to be released from growth 
cones (Kryostosek and Seeds, 1981; Pittman, 1985). AI- 
ternatively, the absence of staining with PNA and C-6- 
S-specific antibodies in the presumptive axon pathways 
may be independent of growth cone invasion, which 
would strongly suggest the evolution of a preformed 
pathway bounded by barriers to axon advance. To distin- 
guish between these alternatives, we examined the pat- 
tern of PNA binding following unilateral neural tube 
deletions. We used PNA because it was possible to label 
both axons and barrier tissues in the same sections. This 
enabled us to precisely evaluate the extent of the dele- 
tion as well as to determine the pattern of barrier 
marker expression. 
We found that the preferential distribution of PNA 
binding in barrier tissues but not in axon pathways is 
independent of axon outgrowth. Figure 7 illustrates the 
pattern of PNA binding at the level of the crural nerve 
trunk in operated embryos at various stages of develop- 
ment. PNA specifically bound to the perinotochordal 
mesenchyme and the early (stage 22) girdle mesen- 
chyme but not to the spinal nerve pathway or plexus 
region even in experimental embryos without any de- 
tectable axons in the relevant segments (Figs. 7A-7B). 
Moreover, the PNA-negative gaps in the girdle mesen- 
chyme that  delineate both the dorsal and the ventral 
crural pathways developed on schedule even in the com- 
plete absence of motor outgrowth and the virtual ab- 
sence of sensory outgrowth (Figs. 7C-F). We also deter- 
mined that  there was no significant difference in the 
overall size of the dorsal crural nerve pathway in oper- 
ated limbs by measuring the anterior-posterior extent 
of the PNA-negative gap in both limbs of stage 25-26 
neural tube-deleted embryos. This nerve pathway con- 
stituted 19% (_+7.5%) of the anterior-posterior extent of 
control limbs and 17% (_+6%) of the anterior-posterior 
extent of experimental limbs. Therefore, it is unlikely 
that  axons enlarge a small preexisting pathway. These 
results strongly suggest that  the lack of PNA binding in 
axon pathways is an independent property of the mesen- 
chyme within these pathways and is not dependent on 
an interaction with growth cones or on the presence of 
axons in the tissue sections. 
PNA Binding and C-6-S Expression in the Limb Bud 
At stages prior to axon invasion, the limb bud tran- 
siently expresses inhibitory properties. Motor neurons 
do not extend axons when cultured on slices of early 
limb buds (stage 18-22), but will extend axons on slices 
of older limbs (Landmesser, 1988). Moreover, axons will 
not enter a young limb bud transplanted to an older host 
until the graft  matures (Swanson and Lewis, 1982). To 
determine whether this transient inhospitible period is 
correlated with the transient expression of markers for 
barrier function, we examined the pattern of PNA bind- 
ing and C-6-S expression at various stages of limb devel- 
opment. 
The early limb bud transiently exhibits a uniform 
pattern of PNA binding and C-6-S immunoreactivity. 
Between stages 18 and 21 (Figs. 3A, 8A-8B) the expres- 
sion of both carbohydrate epitopes is essentially homo- 
geneous with little regional differentiation. As the limb 
matures, both epitopes become largely localized to the 
prechondrogenic region in the core of the limb, which is 
distinctly stained by stage 22 (Figs. 8C-8D). The limb 
regions comprising the prospective nerve pathways and 
the muscle masses are delineated by the absence of 
staining with either PNA- or C-6-S-specific antibodies 
as early as stage 22. Thus, staining with both probes is 
largely confined to the precondrogenic core prior to the 
axon invasion of the hindlimb (stage 24). The transient  
period of uniform expression of these carbohydrate epi- 
topes in the early limb bud therefore correlates with the 
period during which the limb bud is hostile to motor 
growth cone advance. 
Comparison of  Various Markers for Chondrogenic 
Development 
Since PNA binding molecules and chondroitin sulfate 
proteoglycans are typical of chondrogenic differentia- 
tion (Kimata et al., 1986; Aulthouse and Solursh, 1987), 
we also examined the expression of other cartilage pro- 
teoglycan epitopes to determine if they are preferen- 
tially expressed in barrier tissues during axon out- 
growth. Monoclonal antibodies to chondroitin-4-sul- 
fa te /dermatan sulfate (C-4-S/DS) and keratan sulfate 
(KS) did not label all barrier tissues during axon out- 
growth. For example, C-4-S/DS immunoreactivity was 
detected in the perinotochordal mesenchyme, limb core, 
DRG (arrowhead), motor column (double arrowhead), and limb ectoderm (e). Like C-6-S, it is also expressed in the femur (f) and notochord (n). 
Stage 25 chick, n, notochord; s, spinal cord. Calibration bars = 100 tim. 
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FIG. 7. The development of PNA-negative nerve pathways is independent of axon outgrowth as shown by transverse sections of embryos in 
which the left half of the spinal cord (s) has been deleted. (A, B) The same transverse section from the crural region of a stage 22+ embryo that  
had no detectable axon outgrowth on the experimental side. (A) PNA binds the perinotochordal mesenchyme (pnm) and the dorsal (dg) and 
ventral (vg) girdle elements but not the spinal nerve pathway (curved arrows) or plexus region (px) on both the control and the operated (left) 
side. PNA-negative gaps (arrows) between girdle elements have begun to form on both sides. (B) On the operated (left) side of this embryo, no 
axons were detected in this or the two adjacent segments. On the control (right) side, axons in the spinal nerve (curved arrow) have projected as 
far as the plexus region (arrow). (C, D) The same transverse section through the anterior crural region of a stage 25+ embryo with complete 
motor deletion and substantial sensory deletion on the operated side. (C) PNA binds the posterior sclerotome (ps) and girdle elements (dg, vg) 
but not the dorsal (arrows) or ventral (curved arrows) crural nerve pathways. Note that  the size of the PNA-negative pathways is clearly 
normal despite the reduction of axon outgrowth. (D) Axons on the control side have colonized the dorsal (arrow) and ventral (curved arrow) 
crural pathways, but no axons were detected in the ventral crural pathway on the operated (left) side. A few sensory axons remain in the left 
dorsal crural pathway (open arrow). (E, F) The same transverse section through a more posterior portion of the crural region from a stage 25+ 
embryo in which only a small population of sensory axons developed on the operated side. (E) PNA binds the posterior sclerotome (ps) and 
girdle elements (dg, vg) that  demarcate the PNA-negative dorsal crural nerve pathways (arrows) on both the operated (left) and control (right) 
sides. (F) On the operated (left) side, a small contingent of sensory axons has turned upon contact with the girdle (small arrows) and has 
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spinal cord, DRG, and ectoderm but was not detected in 
the posterior sclerotome or in the girdle mesenchyme 
during early axon outgrowth. Moreover, apparently 
lower levels of C-4-S/DS expression were also detected 
within axon pathways (Fig. 6F). KS immunoreactivity 
was only detected in and immediately adjacent to the 
notochord (not shown). Since KS immunoreactivity was 
not detected in barrier tissues with C-6-S immunoreac- 
tivity, it is unlikely that  the C-6-S antibody is binding 
exclusively to the large aggregating proteoglycan of 
cartilage, which bears both epitopes (see Ruoslahti, 1988 
for review). Thus, KS and C-4-S/DS are not selective 
markers for barrier tissues during early axon out- 
growth. 
Although PNA binding sites and C-6-S immunoreac- 
tivity are expressed in similar spatial and temporal pat- 
terns in avian embryos, these patterns are clearly not 
identical. The differences are especially apparent in the 
developing limb bud (Fig. 8); PNA strongly labels the 
ectoderm and its basement membrane at all stages of 
development, whereas, C-6-S antibodies do not label 
these structures. Similarly, PNA discretely labels the 
prechondrogenic core of the limb at stage 22, whereas 
C-6-S immunoreactivity is more widely dispersed. We 
also observed consistent regional differences in staining 
intensity within structures that  were labeled by both 
probes (compare Figs. 8E and 8F). Our results therefore 
suggest that  the two barrier markers we have identified 
are not recognizing the same molecule. 
P N A  Binding and C-6-S Expression in the Developing 
Spinal Cord 
We also found that  both PNA binding sites and C-6-S 
immunoreactivity are expressed in specific patterns in 
the developing spinal cord. Strong PNA binding was de- 
tected in the roof plate and along the lateral margin of 
the spinal cord as early as stage 19 (Fig. 2A, also see 
Figs. 1C-1D). As the spinal cord matured and the lateral 
motor columns became distinct, PNA binding within the 
ventral spinal cord delimits the medial border of the 
motor columns, which were consistently PNA-negative 
(Fig. 5A). This pattern of binding was apparent at all 
subsequent stages examined. Although C-6-S immunore- 
activity was difficult to preserve in the spinal cord, in 
well preserved specimens its distribution was identical 
to that  of PNA (compare Figs. 5A and 5E). These results 
indicate that  PNA binding and C-6-S epitopes are ex- 
pressed in the roof plate of the early chick spinal cord, a 
structure that  is a putative barrier to axon advance 
across the dorsal midline in the early rat  embryo (Snow 
et al., 1990a). 
DISCUSSION 
P N A  and Chondroitin-6-sulfate Are  Markers  f o r  
Barriers  to Axon  Advance  
We have identified two carbohydrate epitopes that  
are preferentially expressed in three tissues that  have 
been experimentally shown to share a similar axon guid- 
ance function in the chick embryo; the pelvic girdle pre- 
cursor, the posterior sclerotome, and the perinotochor- 
dal mesenchyme all provide guidance cues that  result in 
growth cone avoidance and thereby act as barriers to 
axon advance (Tosney and Landmesser, 1984; Keynes 
and Stern, 1984; Stern and Keynes, 1987; Tosney, 1988; 
Tosney and Oakley, 1990). We have shown here that  all 
three of these tissues express both PNA binding sites 
and C-6-S immunoreactivity as growth cones interact 
with and avoid these barrier tissues. Previous studies 
had shown that  PNA binding sites (Stern et al., 1986) 
and chondroitin sulfate proteoglycans (Tan et al., 1987; 
Newgreen et al., 1990) are preferentially expressed in 
the posterior sclerotome. We have extended these find- 
ings by showing that  these carbohydrate epitopes are 
selectively expressed in all three barrier tissues during 
the earliest phases of peripheral axon outgrowth. More- 
over, we have shown that  these epitopes distinguish 
functional barriers to axon advance from prospective 
axon pathways within an otherwise largely homoge- 
neous mesenchyme. 
The strong spatial and temporal correlation between 
experimentally defined barrier function and the expres- 
sion of PNA binding sites and C-6-S immunoreactivity 
suggests that  molecules bearing these epitopes are po- 
tential mediators of barrier function. However, since 
any causal relation between the expression of these epi- 
topes and barrier function remains to be established, we 
conservatively propose that  these epitopes are at least 
reliable molecular markers for barriers to axon ad- 
vance. 
The utility of these markers for identifying axon 
barriers is further demonstrated by our observation 
that  both markers are uniformly expressed in the early 
limb bud mesenchyme, during the period when it may 
act as a transient barrier to axon advance. In  vitro stud- 
ies using living slices of chick embryos have shown that  
the early limb bud (stages 18-22) presents a hostile envi- 
ronment for motor axon outgrowth (Landmesser, 1988). 
In addition, heterochronic transplantation of limb buds 
has shown that  the timing of axon invasion is deter- 
mined by the maturi ty of the limb rather  than by in- 
trinsic properties of the invading growth cones (Swan- 
son and Lewis, 1982). We have shown that  during this 
independently navigated the dorsal crural nerve pathway to extend as far distally as the axons (arrow) on the control (right) side. n, notochord; 
s, spinal cord. Calibration bars = 100 gin. 
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FIG. 8. PNA binding and C-6-S staining within the chick hindlimb are gradually restricted to the prechondrogenic core. (A, C, E) PNA binding 
and (B, D, F) C-6-S immunoreactivity at  matched stages of limb development using transverse sections from the midhindlimb level. Distal is to 
the left. (A, B) During early stages when the limb bud presents a hostile environment for motor axon outgrowth, the distr ibution of PNA 
binding sites and C-6-S immunoreactivity is largely uniform in the limb. Stage 19 embryos. (C, D) During the period when axons are colonizing 
the plexus region proximal to the girdle, PNA binding and C-6-S staining gradually become largely restricted to the prechondrogenic core of the 
limb (c) and to the presumptive girdle (vg; dorsal girdle is not shown). Stage 22 embryos. (E, F) By stage 25, as axons enter  the limb proper, PNA 
binding sites and C-6-S staining are confined to the limb core (c), presumptive girdle elements (dg, vg), and the distal tip of the limb bud. 
Neither epitope is detected in axon pathways; only the dorsal nerve pathway (arrows) is visible in these sections. Note tha t  the two epitopes are 
distr ibuted in a similar but nonidentical pa t tern  at  all stages. For instance, PNA consistently binds more to dorsal than to ventral  mesenchyme 
in the early limb (A) and later  it more sharply delineates the limb core (C, E). Also note tha t  PNA strongly labels the ectoderm and underlying 
basement  membrane whereas C-6-S antibodies do not. Calibration bars = 100 gm. 
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hostile period both PNA binding sites and C-6-S immu- 
noreactivity are uniformly expressed throughout the 
limb bud, again documenting a correlation between spe- 
cific carbohydrate expression and barrier function. We 
have also shown that  axons normally invade the limb 
only after the expression of these epitopes becomes 
largely restricted to the prechondrogenic core of the 
limb, another region avoided by invading axons. 
Our results further suggest that  the cellular and mo- 
lecular mechanisms that mediate the segmental pat- 
terning of axons within the somites may also mediate 
the general guidance of axons in other regions of the 
embryo. The segmental patterning of axons is depen- 
dent on the sclerotome and represents a striking exam- 
ple of axon guidance by general guidance cues; all sub- 
populations of sensory and motor axons respond simi- 
larly by avoiding the posterior sclerotome and the 
specific deployment of motor axons is independent of 
segmental patterning (Tosney, 1988a). The response of 
axons to the perinotochordal mesenchyme and pelvic gir- 
dle precursor is identical on a functional level in that  all 
subpopulations also avoid these tissues. The fact that  
these tissues all share both functional and molecular 
similarities suggests that  the guidance mechanisms 
may be the same in all cases (see Tosney and Oakley, 
1990). 
Patterned Expression o f  Barrier Markers in Neural  
Tube-Deleted Embryos 
The pattern of normal development suggested that  
growth cones might actively participate in the forma- 
tion of PNA-negative pathways through the girdle re- 
gion since these pathways are not clearly delineated 
prior to axonal invasion. However, PNA-negative path- 
ways developed, on schedule, even in the virtual absence 
of axon outgrowth. We can therefore rule out several 
possible explanations for the preferential expression of 
specific carbohydrate epitopes in barrier tissues but not 
in axon pathways. First, this pattern of expression is 
not merely due to the presence of nonstaining axons 
within the pathways; the surgical elimination of the 
vast majority of peripheral axons did not alter the size 
or distribution of PNA-negative pathways. Second, it is 
highly unlikely that  the absence of barrier markers in 
pathways is due to differential digestion by proteases 
released from growth cones, since PNA-negative path- 
ways of normal size and position developed even when 
no axons could be detected within the relevant seg- 
ments. These results also argue that an interaction be- 
tween growth cones and pathway mesenchyme is insuf- 
ficient to explain the differential expression patterns 
reported here. We therefore conclude that  barriers are 
distinct from axon pathways at the molecular level. 
A molecular distinction between paths and barriers is 
also supported by studies that  have identified unique 
cellular and molecular features which distinguish axon 
pathways. Presumptive peripheral axon pathways are 
characterized by widespread cell death and phagocyto- 
sis (Tosney et al., 1988), the expression of butyrlcholin- 
esterase activity (Layer et al., 1988), and the expression 
of a 70-kDa membrane protein (Tanaka et al., 1989). In 
all cases these features have been found to be indepen- 
dent of axon outgrowth. We have documented another 
distinguishing feature of axon pathways; the absence of 
barrier markers, which is an independent characteristic 
of the cells that  comprise these pathways. 
Barrier Function and Neural  Crest Migration 
Neural crest cell migration may be constrained by the 
same tissues that  act as barriers to axon advance. For 
example, crest cells, like motor axons, invade the ante- 
rior but  not the posterior sclerotome (Rickmann et al., 
1985; Bronner-Fraser, 1986; Loring and Erickson, 1987) 
and avoid both the perinotochordal mesenchyme (New- 
green et al., 1986) and the pelvic girdle precursor (Erick- 
son, Oakley, and Tosney, unpublished observations). 
Are the markers we have identified also reliable 
markers for barriers to neural crest cell migration? A 
recent study (Davies et al., 1990) in fact suggested that  
the differential expression of PNA binding sites in the 
posterior sclerotome develops too late to be relevant to 
the patterned migration of crest cells through the so- 
mite. Similarly, Perris and colleagues have recently 
shown that  chondroitin sulfate/keratan sulfate proteo- 
glycans are preferentially expressed in the posterior 
sclerotome after neural crest cells have colonized the 
anterior sclerotome (Perris et al., 1991). We have shown 
here that  both PNA binding sites and C-6-S immunore- 
activity are expressed in the posterior halves of early 
epithelial somites; both epitopes are therefore ex- 
pressed asymmetrically prior to the preferential coloni- 
zation of the anterior sclerotome by the earliest migrat- 
ing neural crest cells (see Loring and Erickson, 1987; 
Teillet et al., 1987). We have recently confirmed the rela- 
tionship between the expression of PNA binding sites 
and the timing of neural crest migration through the 
somite by double labeling with HNK-1 (Schroeter et al., 
1990). On the basis of the early differential expression of 
PNA binding sites and C-6-S immunoreactivity in the 
posterior somite, we suggest that  these epitopes are also 
reliable markers for barriers to neural crest migration. 
If these epitopes are markers for barriers to neural 
crest migration, how can we account for the expression 
of both markers in the prospective premelanocyte path- 
way between the dermamyotome and the ectoderm ? Our 
preliminary results using PNA and HNK-1 indicate 
that  barrier markers are expressed transiently in the 
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premelanocyte pathway and that neural crest cells 
enter this pathway only after a diminution of PNA bind- 
ing (Schroeter et al., 1990). Moreover, since the surgical 
deletion of the dermamyotome eliminates barrier 
marker expression and permits the precocious invasion 
of the premelanocyte pathway (Lasky et al., 1991), this 
pathway may indeed present a transient barrier to 
neural crest migration. 
A x o n s  Avo id  Prechondrogenic  Tissues  
The avoidance of barrier tissues by axons and neural 
crest cells may be related to the common developmental 
fate shared by these tissues; the posterior sclerotome, 
perinotochordal mesenchyme, and pelvic girdle precur- 
sor all differentiate into cartilage and eventually form 
bone. Although the anterior sclerotome also contributes 
to boney structures (Stern and Keynes, 1987), the rela- 
tive contributions of the perinotochordal (barrier) re- 
gion and the more dorsal anterior sclerotome (pathway) 
to the formation of boney structures have not been 
clearly defined. Moreover, the results of both descrip- 
tive and experimental studies suggest that  the vertebral 
bodies are derived from the perinotochordal tissue from 
both halves of a segment (Dalgleish, 1985; Bagnall et aL, 
1988). It is also known that the axon pathway within the 
sclerotome differs from the barrier regions in that  it 
exhibits a lower rate of proliferation (Dalgeish, 1985) 
and a higher incidence of cell death (Tosney et aL, 1988). 
The molecular markers for barrier function that  we 
have identified also appear to be early markers for pre- 
chondrogenic differentiation. Several lines of evidence 
suggest that  PNA binding molecules are typical of pre- 
chondrogenic tissues. First, PNA binding sites have 
been localized to cartilage forming regions prior to the 
onset of overt chondrogenesis. As we have shown here, 
PNA binds the sclerotome, girdle, and limb core at very 
early stages of development, which is in agreement with 
previous studies that  focused on the prechondrogenic 
core of the limb in chick (Aulthouse and Solursh, 1987; 
Hurle et al., 1988) and mouse (Zimmermann and Thies, 
1984), as well as the prechondrogenic centers of the head 
mesenchyme in the chick (Liu and Layer, 1984). Second, 
PNA binding molecules are also expressed in prechon- 
drogenic cellular aggregates in  v i tro prior to the expres- 
sion of other chondrogenic markers such as intense al- 
cian blue staining or type II collagen immunoreactivity 
(Aulthouse and Solursh, 1987). Finally, we have shown 
that the preferential expression of PNA binding mole- 
cules in the perinotochordal mesenchyme is abolished 
following notochord deletion (Tosney and Oakley, 1990). 
Since chondrogenic differentiation in the sclerotome 
has been shown to be dependent on the notochord 
(Kosher and Lash, 1975; Lash and Vasan, 1978; Cheney 
and Lash, 1981), our result suggests that  PNA binding 
molecules are coordinately regulated with chondrogenic 
development. However, it is also noteworthy that nei- 
ther PNA nor C-6-S is an exclusive marker for prechon- 
drogenic development since both probes also label the 
axial dermis and spinal cord and since PNA labels non- 
chondrogenic regions of the limb bud including the ecto- 
derm and apical ectodermal ridge. 
Although the carbohydrate-specific probes used here 
are clearly recognizing some component of early pre- 
chondrogenic tissue, we do not know the precise identity 
of the molecules detected. However, several potential 
candidates among the various chondroitin sulfate pro- 
teoglycans (CSPGs) of cartilage can be considered based 
on a comparison of our results with previous findings. 
First, although CSPGs are major constituents of ma- 
ture cartilage, it is unlikely that  the C-6-S-specific anti- 
body used here is binding exclusively to the large aggre- 
gating CSPG of mature cartilage, since this CSPG is not 
expressed in the core of the limb until stage 25 (Shino- 
mura et al., 1984; Stirpe and Goetinck, 1989). Moreover, 
this CSPG has keratan sulfate side chains (see Ruos- 
lahti, 1988) and we wereunab le  to colocalize keratan 
sulfate immunoreactivity with that  of C-6-S in the early 
limb bud. Second, the spatial and temporal expression 
patterns in the limb that we have described here are 
similar to those described by Kimata and colleagues for 
a large chondroitin sulfate proteoglycan, termed PG-M, 
which is rich in C-6-S moieties and devoid of keratan 
sulfate chains. The expression of PG-M precedes the 
mesenchymal condensation that leads to overt chondro- 
genic differentiation (Kimata et al., 1986; Shinomura et 
al., 1990). PG-M is also expressed by embryonic fibro- 
blasts and may be the chick equivalent of a human fibro- 
blast CSPG, termed versican, which has recently been 
cloned (Zimmerman and Ruoslahti, 1989). Third, it is 
also possible that  the C-6-S-specific probe recognizes 
the cytotactin binding proteoglycan identified by Edel- 
man and colleagues since this CSPG is also preferen- 
tially expressed in the posterior sclerotome during early 
motor outgrowth (Tan et al., 1987). This CSPG is ex- 
pressed by mature chondrocytes (Hoffman et al., 1988) 
but it is presently unclear whether the cytotactin bind- 
ing CSPG is identical with or related to PG-M or the 
large aggregating CSPG of mature cartilage. 
It also seems unlikely that  the two probes used in this 
study are recognizing different epitopes on the same 
molecule. One of the candidate molecules, the cytotactin 
binding CSPG, has been reported to have both CS side 
chains and PNA binding sites (Tan et al., 1987; Crossin et 
al., 1989). However, we found that although PNA bind- 
ing sites and C-6-S immunoreactivity are largely codis- 
tributed, the patterns of expression are clearly not iden- 
tical. In fact, PNA binding sites are generally more 
widely distributed than is C-6-S immunoreactivity. Sim- 
ilar differences have also been noted by Solursh, Ki- 
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mata, and colleagues in comparing PNA binding pat- 
terns with the distribution of PG-M in early limb buds. 
These findings suggest that  molecules other than 
CSPGs also bear the PNA binding epitope. The conclu- 
sion that  the two barrier markers are recognizing more 
than one molecule is also supported by the fact that  
other PNA binding molecules smaller than either PG-M 
or the cytotactin binding CSPG have been identified in 
extracts of somitic (Davies et al., 1990) and limb bud 
mesenchyme (Shinomura et al., 1990). 
Although it is unlikely that  a single molecular entity 
is recognized by both probes, our results do suggest an 
interaction between PNA binding molecules and 
CSPGs. We found that  PNA binding molecules are sta- 
bilized by CPC, which is known to precipitate glycosami- 
noglycans (Kvist and Finnegan, 1970; Young et al., 1989). 
This result suggests that  CSPGs and PNA binding mole- 
cules are coprecipitated during fixation. Although the 
nature of such an interaction is unknown, PNA binding 
molecules could serve as ligands for CSPGs since the 
core proteins of both versican and the CSPG of mature 
cartilage contain lectin-like domains with binding af- 
finities for extended galactose-bearing epitopes (Hal- 
berg et al., 1988; Zimmerman and Ruoslahti, 1989). 
Regardless of the specific identities of the molecules 
detected with the probes used here, it is clear that  
barrier tissues all express epitopes associated with 
early prechondrogenic differentiation during the period 
when growth cones are avoiding these tissues. We sug- 
gest that  growth cones may be capable of recognizing 
and avoiding prechondrogenic tissues. The fact that  
these tissue precursors can be distinguished within an 
otherwise homogeneous mesenchyme by the expression 
of specific markers suggests a possible molecular basis 
for this recognition. 
Expression of  Barr ier  Markers  in the C N S  
The barrier markers we have identified are not only 
expressed in axon barriers in the periphery, but they are 
also expressed in specific regions of the CNS. For exam- 
ple, we have shown here that  both markers are ex- 
pressed in the roof plate of the spinal cord, a putative 
barrier to commissural and DRG axons in the rat  (Snow 
et al., 1990a). PNA binding sites have also been recently 
shown to define the borders between rhombomeres in 
the chick hindbrain (Layer and Alber, 1990), which have 
been suggested to restrict neuronal migration (Fraser et 
al., 1990; Lumsden, 1990). Similarly, both PNA binding 
sites (Cooper and Steindler, 1986; Steindler and Cooper, 
1987) and the cytotactin binding CSPG (Crossin et al., 
1989) are transiently expressed by the cells that  form 
the walls between the functional units (barrels) of the 
somatosensory cortex that  are associated with the vi- 
brissae of the face in the rodent. This pattern of expres- 
sion has been detected during the ingrowth of thalamo- 
cortical axons to the barrel hollows and persists as cor- 
tical dendrites are elaborated within the barrel hollows. 
On the basis of these correlations, it has been suggested 
that  the barrel walls maintain functional domains by 
inhibiting cell migration and the crossing of barrel 
walls by afferents and dendrites (Steindler et al., 1989; 
Crossin et al., 1989). These studies as well as others 
(Steindler and Cooper, 1987; Steindler et aL, 1988) all 
suggest that  the expression of specific carbohydrate 
epitopes is associated with the functional subdivision of 
the CNS. What is unclear from these studies, however, is 
whether the boundaries identified by these probes do, in 
fact, serve to constrain process outgrowth and cellular 
migration. In the case of the peripheral nervous system, 
we have provided strong experimental evidence tha t  
barrier tissues do constrain axon outgrowth. Similar ex- 
perimental approaches will be necessary to determine if 
the same is true for the putative barriers of the CNS. 
The barrier markers we have identified are also ex- 
pressed at the lateral margins of the early spinal cord 
which serves as a pathway for commissural axons dur- 
ing this period of development (Holley and Silver, 1987; 
Yaginuma et al., 1991). Although the lateral marginal 
zone is clearly not a barrier to commissural outgrowth, 
it may be recognized as such by other early populations 
of spinal cord interneurons since they turn away from 
the lateral marginal zone after experimental rotation of 
the spinal cord (Yaginuma and Oppenheim, 1991). If the 
lateral marginal zone is indeed a barrier for some spinal 
interneurons, the population-specific behavior of com- 
missural growth cones may be due to the chemotactic 
influence of the floor plate (Tessier-Levigne et al., 1988; 
Yaginuma and Oppenheim, 1991) or commissural 
growth cones may lack the capacity to recognize barrier 
tissues. 
Cellular and Molecular Mechanisms of  Barr ier  Funct ion  
The correlation between barrier function and specific 
carbohydrate expression, while intriguing, does not nec- 
essarily imply that  these sugar moities, or even the pro- 
teins that  bear them, are mediators of barrier function. 
However, several lines of evidence directly implicate 
PNA binding molecules as mediators of barrier func- 
tion. First, barrier function and differential PNA bind- 
ing are coordinately abolished in the perinotochordal 
mesenchyme following notochord deletion, which sug- 
gests that  the expression of PNA binding or coregulated 
molecules is essential for barrier function (Tosney and 
Oakley, 1990). Second, glycoprotein fractions extracted 
from somites and isolated by PNA affinity chromatogra- 
phy completely inhibit sensory growth cone motility in 
vitro when presented in liposomes. The active compo- 
nents of these extracts are two glycoproteins (48 and 55 
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kDa) that  are preferential ly expressed in the posterior 
sclerotome (Davies et al., 1990). Third, a PNA binding 
glycoprotein (33 kDa) has also been isolated from poste- 
rior tectal membranes. This glycoprotein causes the col- 
lapse of temporal retina growth cones when presented 
in liposomes (Stahl et aL, 1990). While these studies im- 
plicate PNA binding glycoproteins in barr ier  function, 
the absence of PNA binding sites in the posterior sclero- 
tome of the quail embryo (Asomato et al., 1990; and pres- 
ent results) suggests tha t  the PNA binding disaccharide 
(Gal ~ 1-3 GalNac) is not essential for barr ier  function. 
It  is currently unknown if differentially glycosylated 
forms of the glycoproteins identified by Davies et aL 
(1990) are expressed in the quail posterior sclerotome. 
Similarly, a number of studies suggest that  C-6-S- 
bearing molecules are directly involved in the avoidance 
of barrier  tissues by axons and neural crest cells. Tissue 
culture studies of neurite outgrowth have shown that  
chondroitin sulfate (CS) is a poor substrate for sensory 
outgrowth and that  CS, C-6-S, and CSPGs can block the 
growth promoting effects of fibronectin, laminin, and 
collagen (Carbonetto et al., 1983; Verna et al., 1989; Snow 
et al., 1990b). Moreover, both sensory neurites (Verna et 
al., 1989; Snow et al., 1990b) and motor neurites (Oakley 
and Tosney, unpublished observations) that  are growing 
on permissive substrates will turn to avoid substrates 
that  contain CSPGs. Furthermore,  neural crest cell mi- 
gration is also inhibited by CSPGs in  vi tro (Newgreen et 
al., 1986; Tan et al., 1987; Perris  and Johansson, 1987, 
1990). These results all suggest that  the expression of 
CSPGs in barr ier  tissues could directly contribute to the 
avoidance of these regions by axons and neural crest 
cells in  v i va  
How might the expression of specific molecules be 
translated into avoidance behavior by axons and neural 
crest cells? Two different cellular mechanisms with 
very different implications for molecular function de- 
serve consideration. First, as suggested by the work of 
Davies et al. (1990), growth cone collapse upon contact 
with barr ier  tissues could lead to avoidance behavior. 
Growth cone collapse is characterized by the complete 
inhibition of growth cone motility following contact 
with a specific cell type (Kapfhammer et al., 1986, Kapf- 
hammer and Raper, 1987). The loss of motility is tran- 
sient and thus strongly resembles the contact inhibition 
exhibited by a variety of cell types (see Trinkaus, 1984, 
1985). This mechanism implies the existence of a spe- 
cific receptor on all responding populations that  inter- 
acts with a specific ligand expressed in barr ier  tissues. 
Two possible candidates for such ligands are PNA bind- 
ing molecules and C-6-S-bearing molecules since these 
are expressed by all known barriers to axon advance. 
Alternatively, the avoidance of barrier  tissues by 
growth cones and neural crest cells may be based on 
substratum preference. This mechanism entails the 
choice of one permissive substratum over another (Le- 
tourneau, 1975). A substratum preference mechanism 
implies that  any or all molecules tha t  contribute to the 
overall adhesivity or suitability of a substrate would be 
important  (if not individually critical) factors in deter- 
mining growth cone choice. Substratum preference may 
be particularly relevant to guidance by barrier function 
since there is growing evidence that  CSPGs as well as 
other matrix components may restrict  neurite out- 
growth and cellular migration by blocking access to 
substrate adhesion molecules such as laminin and fibro- 
nectin by either masking the cellular binding sites on 
these substrate adhesion molecules (Laterra et al., 1980; 
Rich et al., 1981; Carbonetto et al., 1983; Yamagata et al., 
1986; Lewandowska et aL, 1987; Verna et al., 1989; Yama- 
gata et aL, 1989; see Ruoslahti, 1988 for review) or by 
interacting with cell surface components that  in turn 
block the receptors for these substrate adhesion mole- 
cules (Perris and Johansson, 1987, 1990). 
It  should be possible to distinguish between and es- 
tablish the relative importance of these alternative cel- 
lular mechanisms by directly observing interactions be- 
tween growth cones and barr ier  tissues. Once the nature 
of the cellular mechanism is defined, the problem of 
identifying the molecules responsible for growth cone 
avoidance behavior will be simplified. 
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